T1	HMM 842 863	overall response rate
T2	HMM 932 958	Median time to progression
T3	HMM 1114 1129	median survival
T4	HMM 1264 1325	hematotoxicity, peripheral neuropathy, and arthralgia/myalgia
T5	HMM 1409 1459	ototoxicity, nausea, vomiting, and nephrotoxicity.
T6	HMM 1460 1481	Quality of life (QOL)
